Quetiapine treatment for cannabis use disorder-Reference-Cited by-同舟云学术

Quetiapine treatment for cannabis use disorder

Published:2021-01 Issue: Volume:218 Page:108366
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Mariani John J.,Pavlicova Martina,Jean Choi C.,Basaraba Cale,Carpenter Kenneth M.,Mahony Amy L.,Brooks Daniel J.,Bisaga Adam,Naqvi Nasir,Nunes Edward V.,Levin Frances R.

Funder

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference50 articles.

1. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial;Allsop;JAMA Psychiatry,2014

2. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial;Anton;JAMA,2006

3. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing;Buchan;Addiction,2002

4. Marijuana withdrawal among adults seeking treatment for marijuana dependence;Budney;Addiction,1999

5. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence;Budney;J. Consult. Clin. Psychol.,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial;Journal of Attention Disorders;2024-07-25

2. Emerging pharmacotherapy for the treatment of cannabis use disorder;Expert Opinion on Pharmacotherapy;2024-04-12

3. A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder;Drug and Alcohol Dependence;2024-01

4. Disorders due to Substance Use: Cannabis;Tasman’s Psychiatry;2024

5. Pharmacological Treatment of Substance Use Disorders;Tasman’s Psychiatry;2024